PetMed Express, Inc. Sets Fiscal Third Quarter 2024 Earnings Call
January 29 2024 - 8:30AM
PetMed Express, Inc. (Nasdaq: PETS) (the “Company”), Your Trusted
Pet Health ExpertTM will hold a conference call on Thursday,
February 8, 2024 at 4:30pm Eastern time to discuss its financial
results for the fiscal third quarter ended December 31, 2023.
Financial results will be issued in a press release prior to the
call.
PetMeds’ management will host the conference call, followed by a
question and answer period.
Date: Thursday, February 8, 2024Time: 4:30pm Eastern time
(1:30pm Pacific time)U.S. dial-in number: 877-407-0789
International number: 201-689-8562Webcast: 3Q Webcast Link
Please call the conference telephone number 5-10 minutes prior
to the start time. If you have any difficulty connecting with the
conference call, please contact MZ Group at 561-374-0177.
A telephonic replay of the conference call will also be
available after 7:30 PM Eastern time on the same day through
February 22, 2024.
Toll-free replay number: 844-512-2921International replay
number: 412-317-6671 Replay passcode: 13744200
About PetMed Express
Founded in 1996, PetMeds is Your Trusted Pet Health ExpertTM,
delivering prescription and non-prescription pet medications and
other health products for dogs, cats, and horses at competitive
prices direct to the consumer through its 1-800-PetMeds toll free
number and through its website at www.petmeds.com.
Forward-Looking StatementsThis press release
may contain “forward-looking” statements, as defined in the Private
Securities Litigation Reform Act of 1995 or by the Securities and
Exchange Commission, that involve a number of risks and
uncertainties, including the Company’s ability to meet the
objectives included in its business plan. Important factors that
could cause results to differ materially from those indicated by
such “forward-looking” statements are set forth in Management’s
Discussion and Analysis of Financial Condition and Results of
Operations in the PetMed Express Annual Report on Form 10-K for the
year ended March 31, 2023. The Company’s future results may also be
impacted by other risk factors listed from time to time in its SEC
filings, including, but not limited to, the Company's Form 10-Q and
its Annual Report on Form 10-K.
Investor Contact:MZ North AmericaBrian M.
Prenoveau, CFAinvestor@petmeds.com(561) 489-5315
PetMed Express (NASDAQ:PETS)
Historical Stock Chart
From Jun 2024 to Jul 2024
PetMed Express (NASDAQ:PETS)
Historical Stock Chart
From Jul 2023 to Jul 2024